(Total Views: 628)
Posted On: 07/13/2020 10:23:48 PM
Post# of 148902
“The only doubt I have is how fast we can get an approval.”
I have the same concern. I believe the data will be good, but a larger M2M will be required and the severe trial will need to be fully enrolled and completed. I hope I’m wrong. Regardless, if data is good, I believe we’lll go back above $5 and hold there.
“And whether we can scale production quickly enough.”
I’m not worried about this. As long as leronlimab is approved, manufacturing will come along, with help from Samsung, the U.S. government and other governments.
“On a side note, those of you that have been around a while may remember that I was strongly against us researching COVID initially.”
Same. I believe one of my posts literally stated that I felt CYDY was wasting precious time and money towards COVID instead of focusing on cancer and NASH. If leronlimab shows efficacy, I’ll eat my own words.
I have the same concern. I believe the data will be good, but a larger M2M will be required and the severe trial will need to be fully enrolled and completed. I hope I’m wrong. Regardless, if data is good, I believe we’lll go back above $5 and hold there.
“And whether we can scale production quickly enough.”
I’m not worried about this. As long as leronlimab is approved, manufacturing will come along, with help from Samsung, the U.S. government and other governments.
“On a side note, those of you that have been around a while may remember that I was strongly against us researching COVID initially.”
Same. I believe one of my posts literally stated that I felt CYDY was wasting precious time and money towards COVID instead of focusing on cancer and NASH. If leronlimab shows efficacy, I’ll eat my own words.
(1)
(0)Scroll down for more posts ▼
